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Abstract. The effects of morphine (10 mg/kg), nalorphine (1 and 10 mg/kg), and 
naloxone (1 mg/kg) were studied on the neoeortical release of aeetylcholine (ACh) 
in midpontine pretrigeminal transected rats. Morphine and, to a lesser extent, 
nalorphine decreased ACh release. Naloxone was ineffective alone but antagonized 
the action of morphine. 
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Introduction 
There is good evidence tha t  morphine and related narcotic agonists 
in large doses elevate total  brain acetylcholine (ACh) in rats (Harken et al., 
1957; Giarman and Pepeu, 1964; Agarwal and Bhargava, 1964; Maynert, 
1967) and mice (tIano et al., 1964; Howes et al., 1969). The increase in 
total  brain ACh could be caused by inhibition of acetylcholinesterase 
(ACHE). Although high concentrations of narcotic agonists and antago- 
nists inhibit AChE in vitro (Berheim and Berheim, 1937; Young et al., 
1955; Foldes et al., 1959; Hein and Powell, 1967) such a mechanism is 
probably not responsible for their in vivo effect on total  brain ACh. 
The concentration of morphine required to produce AChE inhibition 
in vivo is achieved only after parenteral administration of nearly lethal 
doses (Johannesson, 1962). Enhanced choline acetyltransferase (ChAc) 
act ivi ty is also unlikely to explain the increase in total  brain ACh found 
after narcotics. Inhibition of ChAc has been reported in vitro (Torda and 
Wolff, 1946; de la Lande and Bentley, 1955; Morris, 1961) as well as 
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in  vivo (Thal and Wajda ,  1968; Da t t a  et al., 1971). Inh ib i t ion  of ChAc 
would lower no t  elevate bra in  ACh. 
Another  possible mechanism by  which morphine and related narcotic 
agonists elevate total  b ra in  ACh could be inhibi t ion  of ACh release from 
central  cholinergic neurons.  An  ACh antirelease effect of morphine  has 
been reported in  cats (Mitchell, 1963) and rabbi ts  (Beleslin and Polak, 
1965; Beleslin et al., 1965). J h a m a n d a s  et al. (197I) showed tha t  this 
antirelease effect was shared by  all narcotic agonists tested as well as 
by  nalorphine,  a well known mixed agonist-antagonist .  The pure anta-  
gonist, naloxone, was devoid of any  ACh antirelease act ion bu t  anta-  
gonized the effect of the narcotic agonists. 
Very recent ly Lundho lm et al. (1972) and  Pepeu et al. (1972) reported 
t ha t  ACh is released from the neoeortex of the rat.  There is no s tudy  of 
the effect of morphine  and  related narcotic  agonists and  antagonists  on 
the release of ACh from ra t  neocortex. This paper presents the charac- 
teristics of ACh release from the neocortex of midpont ine  pretr igeminal  
t ransected rats  as well as on the effect of morphine,  nalorphine and  
naloxone on the neoeortieal release of ACh in  analgesic and behavioral ly  
effective doses. 
Methods 
Twenty-four adult male Holtzman rats weighing between 400 and 500 grams 
were used in these experiments. They were initially anesthetized with a diethyl 
ether-air mixture. When surgical anesthesia was achieved, a trucheotomy was 
performed and a small polyethylene tube inserted into the trachea. It  was thus 
possible to administer additional amounts of anesthetic as required during surgery 
and to assist respiration. Respiratory assistance was necessary in only one case 
throughout all the experiments. The rats were then placed in a Stoelting rat stereo- 
taxic apparatus. A midpontine pretrigeminal transection was performed by a special 
spatula followed by removal of the bone and the dura over the cerebrum in pre- 
paration for placement of the collecting cup. When surgery was complete, the rats 
were given about one hour to recover from the trauma. 
The collecting cup was constructed of brass and was coated with the electrode 
insulating agent, compound 741. The cup covered an area of 0.38 cm 2, which 
included the following Broadman areas: 1, 2, 3, 4, 5, 6, 17, 18, 23, 29 C (Krieg, 1946). 
The cup was filled with a 0.4 ml aliquot of mammalian Locke's solution containing 
(concentration in g/l): NaC1, 9.0; KC1, 0.42; CaCI2, 0.24; NaHCO 3, 0.5; glucose, 1.0; 
and physostigmine sulfate, 0.1. Every 10 rain the cup content was siphoned and 
immediately bioassayed for ACh using the dorsal muscle of the leech, according to 
the method of Murnaghan (1958). 
The muscle was suspended in a 2 ml bath. The upper end of the muscle was 
connected to a small mirror which reflected a beam of light to a graduated scale 
approximately 5 feet away, allowing a 200 fold magnification. 
The samples collected from the cups were diluted with distilled water (1 volume 
diluted to 1.4 volume) for the purpose of achieving inotonicity with leech Locke's 
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solution. The samples were then compared with standard solutions of ACh. C1 
containing the same concentration of physostigmine. In order to assure that maxi- 
mal cholinesterase inhibition had occurred in the area of the cortex beneath the 
cup, samples for the first 10 min interval were not assayed. Evidence that the 
substance released into the cup was either ACh or a very similar choline ester has 
been given previously (Mitchell, 1963; Szerb, 1963; Bartolini and Pepeu, 1967). 
In all experiments, the narcotic agonists and antagonists were injected i.p. 
The doses (calculated as base) were chosen as in the analgesic and behaviorally 
effective range. They are known to affect rat brain ACh utilization (Domino and 
Wilson, 1972). 
R e s u l t s  
E//ects o/Narcotic Agonists and Antagonists on the Release o/ACh 
/tom the Neocortex 
a) Characteristics o/ Spontaneous Release o/ ACh. I t  has previously 
been shown in  midpont ine  pretr igeminal  t ransected cats t ha t  ACh is 
spontaneous ly  released from the neocortex into a cup filled with mam- 
mal ian  Locke's solution. Our results show tha t  ACh is also released from 
the neocortex of rats  when using the same prepara t ion  as with cats. 
Al though the release of ACh varied from animal  to animal,  it  increased 
l inearly dur ing  collection periods of 5, 10 and 15 rain, as shown in Fig. 1. 
The mean  rates of ACh release • S.E. during collections of 5, 10 and  15 
were 2.60 4- 0.16 ng /min /cm 2 from 6 cups in 4 rats, 2.24 4- 0.09 ng/min/  
cm 2 from 59 cups in 22 rats, 2.30 4-0.11 ng /min /cm e from 9 cups in 
5 r~ts. A group comparison t test  showed tha t  there was no significant 
difference between any  of the means ( P )  0.1). 
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Fig. 1. Evidence of linear release of ACh from the rat neocortex. Each point rep- 
resents the mean of at least 4 animals. The amount of ACh is expressed as total 
ACh release in ng/collection period/cm 2 of cortex. For convenience, a 10 min interval 
was used in the remaining study 
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Fig.2. Effects of morphine, nalorphine and naloxone on neocortical ACh release 
in the rat. The four bar graphs (A--D) indicate the time course of action of the 
various narcotics on mean ACh release. A minimum of 4 animals per collection 
period was used. The small vertical lines indicate • S.E. A group comparison "t" 
test when significant from control is indicated by *P < 0.05, **P < 0.01. Symbols 
used also apply to Fig. 3 
Since ACh release was l inear over the first 15 rain, a collection period 
of l0  min  was chosen for convenience. The effect of narcotic agonists and  
antagonists  on neoeortieal ACh release was determined only when the 
control level of ACh ou tpu t  was stable. 
b) E//ects of Narcotic Agonists and Antagonists. In t raper i tonea l  in- 
jection of morphine  in  a dose of 10 mg/kg produced a decrease in 
the release of ACh from neoeortex. The t ime course of the anti-  
release act ion of morphine is shown in Fig. 2A. Twen ty  minutes  after 
inject ion a nadi r  was reached. ACh release remained low for 40 rain 
after injection. The mean  4- S.E. of the a m o u n t  of ACh released a t  20 rain 
was 1.46 ~= 0.16 ng/min/em 2, which represents a 350/0 decrease from 
the mean  of the control values of 2.36 4- 0.19 ng /min /cm 2. Sixty minutes  
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Fig. 3. Antagonism of morphin e ACh antirelease by naloxone in the rat. Naloxone 
completely blocked the ACh antirelease effect of morphine as noted 
after injection of morphine, ACh release was not significantly different 
from control (0.3 > p > 0.2). 
The pure antagonist, naloxone, in a dose of 1 mg/kg did not signifi- 
cantly change the release of ACh through the 90 min sampling period. 
Fig. 2B shows the time course of events. The difference between the 
mean of the controls and the mean of any one of the collection periods 
after injections of the drug was not statistically significant (P > 0.05). 
Nalorphine, a mixed antagonist-agonist, produced a slight decrease 
in the release of ACh from the neoeortex when injected intraperitoneally 
in doses of either 1 or 10 mg/kg. Figs. 2C and 2D show tha t  ACh release 
reached a maximum by 20 min after injection. This onset of action was 
the same as for morphine. The 1 mg/kg of nalorphine caused a 17.4~ 
decrease in ACh release during the 10--20 min collection period, as 
compared with controls (P < 0.1), whereas the 10 mg/kg dose showed 
a 21.5~ decrease (P < 0.05). Throughout the following 70 rain, ACh 
release was not significantly different from controls. 
c) E/Ject o/Naloxone on the Reduction o/ACh Release by Morphine. 
When naloxone (1 mg/kg) and morphine (10 mg/kg) were simultaneously 
injected intraperitoneally, the reduction in ACh release produced by  
morphine was essentially reversed. Fig.3 shows the t ime course of 
morphine alone and with naloxone. The difference between the mean 
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for controls and the mean for any one of the collecting periods for 
naloxone-morphine was not statistically significant (P > 0.7). 
Discussion 
This preliminary study demonstrates conclusively tha t  the acute 
pretrigeminal midpontine transected rat  preparation is suitable for 
measuring the release of ACh from the neocortex. ACh release is linear 
with time. The total  amount of ACh released is slightly higher than tha t  
obtained in the cat. 
Evidence tha t  morphine in reasonable analgesic doses reduces rat  
cortical release of ACh for about one hour, confirms similar results in the 
cat (Jhamandas et al., 1971 ; Labreeque and Domino, unpublished obser- 
vation, 1972). The data are also consistent with the observation tha t  this 
dose of morphine is very effective in preventing brain ACh depletion 
induced by HC-3 (Domino and Wilson, 1972). An especially important  
observation is that  in the rat, nalorphine also reduces ACh release, but  
the effect is transient with recovery in 30 rain. This explains the failure 
of Domino and Wilson (1972) to show that  nalorphine has an agonistic 
effect on brain ACh depletion in the rat. In  contrast to the very short 
duration of action of nalorphine in the rat,  in the cat it has a longer ACh 
antirelease effect than morphine (Labreeque and Domino, unpublished 
observation, 1972). As would be expected, naloxone, a pure antagonist, 
in the dose used did not alter ACh release from the rat  neocortex. 
However, it did prevent the effect of morphine when given simultane- 
ously. 
A major criticism of the present study is the failure to do complete 
dose-effect curves. Such data is already available for the anti-ACh 
depleting effects of narcotic analgesics in the rat  (Domino and Wilson, 
1973). The present study further supports the hypothesis tha t  morphine 
and related narcotic agonists reduce brain ACh release in the rat  as well 
as the cat (Jhamandas et al., 1971) and the rabbit  (Bcleslin et al., 1965). 
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